FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2798021351> ?p ?o ?g. }

• W2798021351 endingPage "157" @default.
• W2798021351 startingPage "148" @default.
• W2798021351 abstract "There are limited data on uninterrupted anticoagulation with direct oral anticoagulants during catheter ablation for atrial fibrillation (AF), particularly in Japan. We planned a subgroup analysis of the RE-CIRCUIT study, comparing the use of uninterrupted dabigatran therapy with warfarin therapy during catheter ablation among the Japanese subgroup and with that in the total population.The RE-CIRCUIT study utilized a prospective, randomized, open-label, blinded endpoint design, and the primary endpoint was the incidence of major bleeding events (MBEs). Patients were randomized to uninterrupted dabigatran 150 mg twice daily or warfarin. In this study, we analyzed the results in Japanese patients.Of 704 enrolled patients in the study, 112 Japanese patients were randomized to dabigatran (n = 65) or warfarin (n = 47). MBEs were experienced by two patients: one in the dabigatran group (1.6%, cardiac tamponade) and one in the warfarin group (2.2%, groin hematoma) (risk difference vs warfarin -0.6%; 95% CI -5.8, 4.7). Within the Japanese subgroup, there were no thromboembolic events in both groups.While not designed to show statistical difference between two treatment groups, our results from the Japanese subgroup supported those from the overall population. Furthermore, this study provided clinical information regarding MBE, especially cardiac tamponade, in Japanese patients." @default.
• W2798021351 created "2018-04-24" @default.
• W2798021351 creator A5009871378 @default.
• W2798021351 creator A5010491253 @default.
• W2798021351 creator A5013562188 @default.
• W2798021351 creator A5021691991 @default.
• W2798021351 creator A5023118044 @default.
• W2798021351 creator A5025867572 @default.
• W2798021351 creator A5035011651 @default.
• W2798021351 creator A5043101028 @default.
• W2798021351 creator A5056522927 @default.
• W2798021351 creator A5064436070 @default.
• W2798021351 creator A5067383447 @default.
• W2798021351 creator A5081007779 @default.
• W2798021351 creator A5082038216 @default.
• W2798021351 creator A5084183964 @default.
• W2798021351 date "2018-01-13" @default.
• W2798021351 modified "2023-09-26" @default.
• W2798021351 title "Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial" @default.
• W2798021351 cites W1489535640 @default.
• W2798021351 cites W1586488555 @default.
• W2798021351 cites W1675677194 @default.
• W2798021351 cites W1968678408 @default.
• W2798021351 cites W1986637035 @default.
• W2798021351 cites W1997305493 @default.
• W2798021351 cites W2012838115 @default.
• W2798021351 cites W2018856451 @default.
• W2798021351 cites W2023143117 @default.
• W2798021351 cites W2035582101 @default.
• W2798021351 cites W2120775803 @default.
• W2798021351 cites W2165141146 @default.
• W2798021351 cites W2167850919 @default.
• W2798021351 cites W2207637718 @default.
• W2798021351 cites W2276809808 @default.
• W2798021351 cites W2527540058 @default.
• W2798021351 cites W2595627091 @default.
• W2798021351 cites W2989714602 @default.
• W2798021351 cites W3030533492 @default.
• W2798021351 cites W4238531734 @default.
• W2798021351 doi "https://doi.org/10.1002/joa3.12024" @default.
• W2798021351 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5891433" @default.
• W2798021351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29657590" @default.
• W2798021351 hasPublicationYear "2018" @default.
• W2798021351 type Work @default.
• W2798021351 sameAs 2798021351 @default.
• W2798021351 citedByCount "4" @default.
• W2798021351 countsByYear W27980213512019 @default.
• W2798021351 countsByYear W27980213512020 @default.
• W2798021351 crossrefType "journal-article" @default.
• W2798021351 hasAuthorship W2798021351A5009871378 @default.
• W2798021351 hasAuthorship W2798021351A5010491253 @default.
• W2798021351 hasAuthorship W2798021351A5013562188 @default.
• W2798021351 hasAuthorship W2798021351A5021691991 @default.
• W2798021351 hasAuthorship W2798021351A5023118044 @default.
• W2798021351 hasAuthorship W2798021351A5025867572 @default.
• W2798021351 hasAuthorship W2798021351A5035011651 @default.
• W2798021351 hasAuthorship W2798021351A5043101028 @default.
• W2798021351 hasAuthorship W2798021351A5056522927 @default.
• W2798021351 hasAuthorship W2798021351A5064436070 @default.
• W2798021351 hasAuthorship W2798021351A5067383447 @default.
• W2798021351 hasAuthorship W2798021351A5081007779 @default.
• W2798021351 hasAuthorship W2798021351A5082038216 @default.
• W2798021351 hasAuthorship W2798021351A5084183964 @default.
• W2798021351 hasBestOaLocation W27980213511 @default.
• W2798021351 hasConcept C126322002 @default.
• W2798021351 hasConcept C164705383 @default.
• W2798021351 hasConcept C168563851 @default.
• W2798021351 hasConcept C187960798 @default.
• W2798021351 hasConcept C203092338 @default.
• W2798021351 hasConcept C2776131983 @default.
• W2798021351 hasConcept C2776301958 @default.
• W2798021351 hasConcept C2777573719 @default.
• W2798021351 hasConcept C2778607678 @default.
• W2798021351 hasConcept C2778810321 @default.
• W2798021351 hasConcept C2779161974 @default.
• W2798021351 hasConcept C2908647359 @default.
• W2798021351 hasConcept C42219234 @default.
• W2798021351 hasConcept C44249647 @default.
• W2798021351 hasConcept C71924100 @default.
• W2798021351 hasConcept C99454951 @default.
• W2798021351 hasConceptScore W2798021351C126322002 @default.
• W2798021351 hasConceptScore W2798021351C164705383 @default.
• W2798021351 hasConceptScore W2798021351C168563851 @default.
• W2798021351 hasConceptScore W2798021351C187960798 @default.
• W2798021351 hasConceptScore W2798021351C203092338 @default.
• W2798021351 hasConceptScore W2798021351C2776131983 @default.
• W2798021351 hasConceptScore W2798021351C2776301958 @default.
• W2798021351 hasConceptScore W2798021351C2777573719 @default.
• W2798021351 hasConceptScore W2798021351C2778607678 @default.
• W2798021351 hasConceptScore W2798021351C2778810321 @default.
• W2798021351 hasConceptScore W2798021351C2779161974 @default.
• W2798021351 hasConceptScore W2798021351C2908647359 @default.
• W2798021351 hasConceptScore W2798021351C42219234 @default.
• W2798021351 hasConceptScore W2798021351C44249647 @default.
• W2798021351 hasConceptScore W2798021351C71924100 @default.
• W2798021351 hasConceptScore W2798021351C99454951 @default.
• W2798021351 hasFunder F4320310441 @default.
• W2798021351 hasIssue "2" @default.

• next